Oncogene - Table of Contents alert Volume 35 Issue 4

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 35, Issue 4 (January 2016) In this issue Review Original Articles Short Communication Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Oncogenesis is an online-only, open access journal exploring the molecular basis of cancer and related phenomena. The journal seeks to promote diverse and integrated areas of molecular biology, cell biology, oncology, and genetics. The journal has an Impact Factor of 3.952. Explore the benefits of submitting your next research article. Review Top The oncogene ERG: a key factor in prostate cancer P Adamo and M R Ladomery Oncogene 2016 35: 403-414; advance online publication, April 27, 2015; 10.1038/onc.2015.109 Abstract | Full Text Original Articles Top The NEDD8 inhibitor MLN4924 increases the size of the nucleolus and activates p53 through the ribosomal-Mdm2 pathway A Bailly, A Perrin, L J Bou Malhab, E Pion, M Larance, M Nagala, P Smith, M-F O'Donohue, P-E Gleizes, J Zomerdijk, A I Lamond and D P Xirodimas Oncogene 2016 35: 415-426; advance online publication, April 13, 2015; 10.1038/onc.2015.104 Abstract | Full Text Betulinic acid induces a novel cell death pathway that depends on cardiolipin modification L Potze, S Di Franco, C Grandela, M L Pras-Raves, D I Picavet, H A van Veen, H van Lenthe, F B Mullauer, N N van der Wel, A Luyf, A H C van Kampen, S Kemp, V Everts, J H Kessler, F M Vaz and J P Medema Oncogene 2016 35: 427-437; advance online publication, April 20, 2015; 10.1038/onc.2015.102 Abstract | Full Text An antibody to amphiregulin, an abundant growth factor in patients’ fluids, inhibits ovarian tumors S Carvalho, M Lindzen, M Lauriola, N Shirazi, S Sinha, A Abdul-Hai, K Levanon, J Korach, I Barshack, Y Cohen, A Onn, G Mills and Y Yarden Oncogene 2016 35: 438-447; advance online publication, April 27, 2015; 10.1038/onc.2015.93 Abstract | Full Text MiRNA-621 sensitizes breast cancer to chemotherapy by suppressing FBXO11 and enhancing p53 activity OPEN J Xue, Y Chi, Y Chen, S Huang, X Ye, J Niu, W Wang, L M Pfeffer, Z-m Shao, Z-H Wu and J Wu Oncogene 2016 35: 448-458; advance online publication, April 13, 2015; 10.1038/onc.2015.96 Abstract | Full Text Inhibition of B-Raf/MEK/ERK signaling suppresses DR5 expression and impairs response of cancer cells to DR5-mediated apoptosis and T cell-induced killing Y-T Oh, J Deng, P Yue, T K Owonikoko, F R Khuri and S-Y Sun Oncogene 2016 35: 459-467; advance online publication, April 13, 2015; 10.1038/onc.2015.97 Abstract | Full Text Elevated CDCP1 predicts poor patient outcome and mediates ovarian clear cell carcinoma by promoting tumor spheroid formation, cell migration and chemoresistance Y He, A C Wu, B S Harrington, C M Davies, S J Wallace, M N Adams, J S Palmer, D K Roche, B G Hollier, T F Westbrook, H Hamidi, G E Konecny, B Winterhoff, N P Chetty, A J Crandon, N B Oliveira, C M Shannon, A V Tinker, C B Gilks, J I Coward, J W Lumley, L C Perrin, J E Armes and J D Hooper Oncogene 2016 35: 468-478; advance online publication, April 20, 2015; 10.1038/onc.2015.101 Abstract | Full Text Low expression of pro-apoptotic Bcl-2 family proteins sets the apoptotic threshold in Waldenström macroglobulinemia B T Gaudette, B Dwivedi, K S Chitta, S Poulain, D Powell, P Vertino, X Leleu, S Lonial, A A Chanan-Khan, J Kowalski and L H Boise Oncogene 2016 35: 479-490; advance online publication, April 20, 2015; 10.1038/onc.2015.103 Abstract | Full Text SCP1 regulates c-Myc stability and functions through dephosphorylating c-Myc Ser62 W Wang, P Liao, M Shen, T Chen, Y Chen, Y Li, X Lin, X Ge and P Wang Oncogene 2016 35: 491-500; advance online publication, April 20, 2015; 10.1038/onc.2015.106 Abstract | Full Text Fer tyrosine kinase oligomer mediates and amplifies Src-induced tumor progression C Oneyama, Y Yoshikawa, Y Ninomiya, T Iino, S Tsukita and M Okada Oncogene 2016 35: 501-512; advance online publication, April 13, 2015; 10.1038/onc.2015.110 Abstract | Full Text Tyr99 phosphorylation determines the regulatory milieu of tumor suppressor p73 Y K Satija and S Das Oncogene 2016 35: 513-527; advance online publication, April 20, 2015; 10.1038/onc.2015.111 Abstract | Full Text Short Communication Top Negative regulation of the p300-p53 interplay by DDX24 D Shi, C Dai, J Qin and W Gu Oncogene 2016 35: 528-536; advance online publication, April 13, 2015; 10.1038/onc.2015.77 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.